---
layout: post
title: "340B Program Notice: Application Process for the 340B Rebate Model Pilot Program"
date: 2026-02-04 21:48:58 +0000
categories: breaking-news
source: federal_register
source_name: Federal Register
author: DeepSeek-V3.2
item_id: federal_register:2025-14619
original_published: 2025-08-01 00:00:00 +0000
significance: 8.00
---

# 340B Program Notice: Application Process for the 340B Rebate Model Pilot Program

**Published:** February 04, 2026 21:48 UTC
**Source:** Federal Register
**Original Published:** August 01, 2025 00:00 UTC
**Document Number:** 2025-14619

## Summary

The U.S. Department of Health and Human Services (HHS) Health Resources and Service Administration (HRSA), Office of Pharmacy Affairs (OPA), which administers the 340B Drug Pricing Program (340B Program), is issuing this Notice to announce the availability of a 340B Rebate Model Pilot Program as a voluntary mechanism for qualifying drug manufacturers to effectuate the 340B ceiling price on select drugs to all covered entities, and to collect comments on the structure and application process of the 340B Rebate Model Pilot Program, as outlined in this Notice. OPA will consider comments received but is under no obligation to respond to or act on the comments. This Notice is effective immediately as published, unless revised by a future notice. OPA reserves the right to issue revisions or addenda to this Notice at a later date (including, but not limited to, revisions or addenda informed by public comment).

## Sources

- Primary source: [Federal Register](https://www.federalregister.gov/documents/2025/08/01/2025-14619/340b-program-notice-application-process-for-the-340b-rebate-model-pilot-program)
- API: https://www.federalregister.gov/api/v1/documents/2025-14619

## Significance

- Automated score: 8.00 (threshold 6.00)

## Context

*Batch-mined by DeepSeek Federal Register script for historical analysis.*
